Method for producing 4-borono-l-phenylalanine having 18f atom introduced thereinto, and precursor of 4-borono-l-phenylalanine having 18f atom introduced thereinto

US2017015684A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017015684-A1
Application numberUS-201515122118-A
CountryUS
Kind codeA1
Filing dateJan 28, 2015
Priority dateFeb 28, 2014
Publication dateJan 19, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

18 F-labeled 4-boronophenylalanine (BPA) can be produced by preparing and further processing a precursor of 18 F-labeled BPA represented by the following formula: in which R 1 represents a bromo group, an iodo group, a fluoro group, a diazaborinane derivative, BX3 − or BX3 − M + (wherein X represents a halogen atom; and M + represents a monovalent monoatomic cation, a polyatomic cation or a complex cation).

First claim

Opening claim text (preview).

1 . A compound represented by a formula below: wherein R 1 represents bromo group, iodo group, fluoro group, a diazaborinane derivative, BX 3 − , or BX 3 − M + (X represents halogen, and M + represents monovalent monoatomic cation, polyatomic cation, or complex cation). 2 . The compound according to claim 1 , wherein X represents F, and M + represents an alkali metal ion, an ammonium ion, a tetraalkylammonium ion, a tetraarylammonium ion, a tetraalkylphosphonium ion, a tetraarylphosphonium ion, or an imidazolium ion. 3 . A method for producing a compound represented by a formula below: where R 1 represents bromo group, iodo group, fluoro group, a diazaborinane derivative, BX 3 − , or BX 3 − M + (X represents halogen, and M + represents monovalent monoatomic cation, polyatomic cation, or complex cation), comprising: using a compound represented by a formula below: where R 1 represents bromo group, iodo group, fluoro group, a diazaborinane derivative, BX 3 − , or BX 3 − M + (X represents halogen, and M + represents monovalent monoatomic cation, polyatomic cation, or complex cation), and R 2 represents any one selected from the group consisting of halogen, amino group, nitro group, boronic acid, boronic acid ester, OSO 2 R 3 , NR 4 R 5 , and N + R 4 R 5 R 6 R 7 (where R 3 represents alkyl group having 1 to 7 carbon atoms, halogen-substituted alkyl group having 1 to 7 carbon atoms, or optionally substituted phenyl group; R 4 and R 5 , which are the same or different, each represent alkyl group having 1 to 7 carbon atoms, halogen-substituted alkyl group having 1 to 7 carbon atoms, or optionally substituted phenyl group, or R 4 and R 5 are combined together with N to form a 3- to 7-membered cyclic structure; R 6 represents alkyl group having 1 to 7 carbon atoms; and R 7 represents halogen or sulfonate). 4 . A method for producing 18 F-labeled 4-boronophen dalanine BPA, comprising: using a compound represented by a formula below: where R 1 represents bromo group, iodo group, fluoro group, chloro group, nitro group, amino group, a diazaborinane derivative, BX 3 − , or BX 3 − M + (X represents halogen, and M + represents monovalent monoatomic cation, polyatomic cation, or complex cation). 5 . The method for producing 18 F-labeled BPA according to claim 4 , wherein X represents F, and M + represents an alkali metal ion, an ammonium ion, a tetraalkylammonium ion, a tetraarylammonium ion, a tetraalkylphosphonium ion, a tetraarylphosphonium ion, or an imidazolium ion.

Assignees

Inventors

Classifications

  • by introduction of halogen; by substitution of halogen atoms by other halogen atoms · CPC title

  • C07F5/025Primary

    Boronic and borinic acid compounds · CPC title

  • Introduction of isotopes of elements into organic compounds {; Labelled organic compounds per se} · CPC title

  • containing halogen · CPC title

  • Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017015684A1 cover?
18 F-labeled 4-boronophenylalanine (BPA) can be produced by preparing and further processing a precursor of 18 F-labeled BPA represented by the following formula: in which R 1 represents a bromo group, an iodo group, a fluoro group, a diazaborinane derivative, BX3 − o…
Who is the assignee on this patent?
Stella Pharma Corp, Univ Osaka Prefect Public Corp
What technology area does this patent fall under?
Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).